The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Applying radiomics to predict pathology of post chemotherapy retroperitoneal nodal masses in germ cell tumors (GCT).
 
Jeremy Howard Lewin
No Relationships to Disclose
 
Paul Dufort
No Relationships to Disclose
 
Jaydeep Halankar
No Relationships to Disclose
 
Martin O'Malley
No Relationships to Disclose
 
Michael A.S. Jewett
Employment - Impact Genetics (I)
Leadership - Impact Genetics (I)
Stock and Other Ownership Interests - Impact Genetics (I)
Honoraria - Janssen Oncology; Myriad Genetics; Pfizer
Consulting or Advisory Role - Theralase
Research Funding - Olympus Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent application filed for a new RFA device
 
Robert James Hamilton
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen
Consulting or Advisory Role - Bayer
Research Funding - Janssen
 
Abha A. Gupta
No Relationships to Disclose
 
Armando J. Lorenzo
No Relationships to Disclose
 
Jeffrey Traubici
No Relationships to Disclose
 
Madhur Nayan
No Relationships to Disclose
 
Ricardo Romao Nazario Leao
No Relationships to Disclose
 
Padraig Richard Warde
No Relationships to Disclose
 
Peter W. M. Chung
Honoraria - Abbvie
Research Funding - Sanofi (Inst)
 
Lynn Anson-Cartwright
No Relationships to Disclose
 
Joan Sweet
No Relationships to Disclose
 
Aaron Richard Hansen
No Relationships to Disclose
 
Ur Metser
Consulting or Advisory Role - Abbvie (Inst)
 
Philippe L. Bedard
Consulting or Advisory Role - Genentech/Roche (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Oncothyreon (Inst); PTC Therapeutics (Inst); Sanofi (Inst); SERVIER (Inst); SignalChem (Inst)